Search Results - subject:"immunization program"

Mendiratta, Gaurav (contributor); … - 2007 - Rev. March, 2007

Persistent link: https://www.econbiz.de/10003753577

The impact of an AIDS vaccine in developing countries : a new model and initial results

Stover, John; Bollinger, Lori; Hecht, Robert; Williams, … - In: Health affairs : at the intersection of health, health … 26 (2007) 4, pp. 1147-1158

Persistent link: https://www.econbiz.de/10003519957

Implementing a public subsidy for vaccines

Sloan, Frank A.; Eesley, Charles E. - In: Pharmaceutical innovation : incentives, competition, …, (pp. 107-126). 2007

Persistent link: https://www.econbiz.de/10003498972

Ensuring the future supply of vaccines : is a national vaccine authority the answer?

Lichtenberg, Frank R. - In: Pharmaceutical innovation : incentives, competition, …, (pp. 127-149). 2007

Persistent link: https://www.econbiz.de/10003498975

Using contingent valuation in hypothetical settings : estimating the WTP for an HIV/AIDS vaccine

Keyserlingk, Camilla von; Rhodes, Bruce - In: Journal of interdisciplinary economics 18 (2007) 1, pp. 71-89

Persistent link: https://www.econbiz.de/10003566933

Drug and vaccine pricing and innovation : what is the story? ; commentary

Pauly, Mark V. - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 407-413

Persistent link: https://www.econbiz.de/10003543692

Vaccination externalities

Boulier, Bryan L. (contributor); … - In: The B.E. journal of economic analysis & policy 7 (2007) 1, pp. 1-25

Persistent link: https://www.econbiz.de/10003741681

The Cost-Effectiveness of Rotavirus Vaccination from Different Perspectives

Jit, Mark - 2007

Rotavirus is the leading cause of acute gastroenteritis in children. In the United Kingdom, it causes significant short-term morbidity, and places a substantial burden on the health service. Two rotavirus vaccines have completed clinical trials and are being considered for routine infant...

Persistent link: https://www.econbiz.de/10012776787

Critical Prevalence of Antibodies for Vaccination Programmes with and Without Screening for Antobodies Against Hepatitis a, Hepatitis B, Varicella, Measles and Tetanus in Catalonia, Spain

Plans-Rubio, Pedro - 2007

BACKGROUND: The prevalence of seropositive individuals that makes cost-effectiveness of vaccinating all individuals equal to that for screening and vaccination of susceptible individuals is defined as the critical prevalence of antibodies (p*). The objective of this study was to derive the...

Persistent link: https://www.econbiz.de/10014055622

Cost-Effectiveness of 23-Valent Pneumococcal Vaccine in Catalonia (Spain)

Plans-Rubio, Pedro - 2007

OBJECTIVE: In this study, cost-effectiveness of the 23-valent pneumococcal vaccination was assessed in Catalonia (Spain). METHODS: Cost-effectiveness was measured in terms of cost per life year gained (LYG), comparing net program costs and effectiveness. The net program cost was calculated from...

Persistent link: https://www.econbiz.de/10014055624